MADRID — Treatment with tisotumab vedotin (Tivdak) significantly extended overall survival (OS) compared with chemotherapy in patients with recurrent or metastatic cervical cancer… Read More
For months, Sen. Bernie Sanders (I-VT) refused to hold a hearing on Dr. Monica Bertagnolli’s nomination to lead the National Institutes of Health. Sand… Read More
Scinai announced positive results suggesting the therapeutic potential of its anti-IL-17 VHH antibodies (NanoAbs) in treating plaque psoriasis
The preclinical study showed that the… Read More
Radiopharmaceuticals are an emerging and promising approach for diagnosing and treating various types of cancer. Radiopharmaceutical therapy (RPT) has demonstrated effectiveness with minimal… Read More
Cullen is a neonatologist and pediatrician.
Over the next few months, most of the U.S. will experience the annual explosion of respiratory infection… Read More
Antibodies Industry Data Book | Forecast 2030
Antibodies Industry Data Book - Antibodies Production, Polyclonal Antibody, Monoclonal Antibody, Cancer Monoclonal Antibody, Research Antibody… Read More
Antibody drug conjugate (ADC) research involves more and more targets, such as HER-2, Trop-2, Claudin-18.2, B7-H3 and B7-H4, etc. Trop-2 is a transmembrane glycoprotein. Its high expres… Read More
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Glioblastoma pipeline constitutes 195+ key companies continuously working towards developing 210+ Gliob… Read More
Biotechnology Have Any Scope
Selective breeding has many advantages; for instance, it enables wheat to reach taller heights and more submissive dogs to be produced. Furthermore, selective br… Read More
Scinai Immunotherapeutics, a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products, recently finalized a major rebrand, chan… Read More